Centessa Pharmaceuticals plc (CNTA)
↓ Download CSV- Sector Manufacturing
- Incorporated X0
- Fiscal year ends Dec 31
In fiscal 2025, Centessa Pharmaceuticals plc reported revenue of $15.00M. The company ran a net loss, with a net margin of -1316.9%. It held $687.50M in total assets against $160.63M in total liabilities.
Key ratios (FY2025)
-1384.6%
Operating margin
-1316.9%
Net margin
-37.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $15.00M | $0 | $6.85M | $0 | — | — | — |
| Operating Income | -$207.69M | -$201.06M | -$171.28M | -$212.26M | — | -$10.44M | -$5.05M |
| Net Income | -$197.53M | -$235.76M | -$151.09M | -$216.21M | — | -$10.66M | -$5.06M |
| EPS (Diluted) | $-1.46 | $-2.06 | $-1.57 | $-2.31 | — | — | — |
| Total Assets | $687.50M | $576.80M | $360.25M | $444.31M | $629.63M | $11.72M | — |
| Total Liabilities | $160.63M | $175.25M | $124.00M | $108.14M | $138.08M | $8.62M | — |
| Shareholders' Equity | $526.86M | $401.55M | $236.24M | $336.17M | $491.55M | — | — |
| Cash & Equivalents | $61.30M | $383.22M | $128.03M | $393.64M | $595.08M | $7.23M | — |
| Operating Cash Flow | -$193.82M | -$142.06M | -$160.34M | -$200.55M | — | -$10.63M | -$5.83M |
| Capital Expenditures | $371.0K | $34.0K | $169.0K | $1.14M | — | $0 | $0 |
| Shares Outstanding | 149.23M | 132.63M | 98.77M | 94.84M | 89.99M | 0 | — |